Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Virtual Event
Webinar: Keeping Claims on Track During COVID-19
On-Demand
Case management provides a crucial role in keeping claims on track and achieving return to work or maximum medical improvement.
Mitchell
News Release
Podcast: Michele Hibbert-Iacobacci Talks Michigan No-Fault Reform With AM Best Radio
Mitchell's Michele Hibbert-Iacobacci joined AM Best Radio to discuss the Michigan no-fault auto insurance reform.
Mitchell
News Release
AM Best: COVID-19 Influence on Workers' Compensation Could Be a Lasting Market Changer
AM Best's News Service interviewed Mitchell's Michele Hibbert-Iacobacci about how the COVID-19 pandemic is affecting the workers' compensation indu
WorkCompWire
Article
WorkCompWire: When Red Flags Appear, IMEs Provide Insight to Take the Next Step on a Claim
By Richard Leonardo, Senior VP of IME and Specialty Services, Genex Services
Mitchell
News Release
Find Nearby Diagnostic Scanning Services
Mitchell
Virtual Event
2020 mPower Virtual Conference
On-Demand
Over the past several months, the Mitchell | Genex teams have been closely monitoring the developments surrounding COVID-19 and the CDC’s recommend